デフォルト表紙
市場調査レポート
商品コード
1317679

ドラッグデリバリー市場:経口デリバリー、デバイスタイプ、流通チャネル、用途別-2023-2030年の世界予測

Drug Delivery Market by Oral Drug Delivery, Device Type, Distribution Channels, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 197 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
ドラッグデリバリー市場:経口デリバリー、デバイスタイプ、流通チャネル、用途別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ドラッグデリバリーの世界市場は大きく成長し、2023年には17億2,009万米ドルが予測され、CAGRは6.38%、2030年には26億5,896万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のドラッグデリバリー市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の発売、未開拓地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.ドラッグデリバリーの世界市場規模および予測は?

2.予測期間中、世界のドラッグデリバリー市場を形成するCOVID-19の阻害要因と影響は?

3.ドラッグデリバリーの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.ドラッグデリバリーの世界市場における競争戦略は?

5.ドラッグデリバリーの世界市場における技術動向と規制の枠組みは?

6.ドラッグデリバリーの世界市場における主要ベンダーの市場シェアは?

7.ドラッグデリバリーの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で生物学的医薬品の使用が増加
      • 効果的なドラッグデリバリーメカニズムに対する需要の高まり
      • 慢性疾患の大幅な増加
    • 抑制要因
      • 医薬品のリコールと医薬品の失敗の増加
      • 薬に伴う副作用とリスク
    • 機会
      • 費用対効果の高いヘルスケア治療に対する需要の高まり
      • 在宅ケアと自己管理への注目の高まり
    • 課題
      • 価格圧力と特許有効期限の問題
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 ドラッグデリバリー市場 口頭でのドラッグデリバリー別

  • 注入可能なドラッグデリバリー
  • 鼻のドラッグデリバリー
  • 眼科のドラッグデリバリー
  • 肺ドラッグデリバリー
  • 話題のドラッグデリバリー

第7章 ドラッグデリバリー市場デバイスタイプ別

  • 高度
  • 従来型

第8章 ドラッグデリバリー市場流通チャネル別

  • 病院薬局
  • 小売薬局

第9章 ドラッグデリバリー市場:用途別

  • がん
  • 心血管疾患
  • 糖尿病
  • 呼吸器疾患

第10章 南北アメリカのドラッグデリバリー市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のドラッグデリバリー市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのドラッグデリバリー市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第14章 掲載企業一覧

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. DRUG DELIVERY MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DELIVERY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2022 VS 2030 (%)
  • FIGURE 5. DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2022 VS 2030 (%)
  • FIGURE 6. DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2022 VS 2030 (%)
  • FIGURE 7. DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 8. DRUG DELIVERY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. DRUG DELIVERY MARKET DYNAMICS
  • FIGURE 10. DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 5. DRUG DELIVERY MARKET SIZE, BY INJECTABLE DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DELIVERY MARKET SIZE, BY NASAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DRUG DELIVERY MARKET SIZE, BY OCULAR DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. DRUG DELIVERY MARKET SIZE, BY PULMONARY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. DRUG DELIVERY MARKET SIZE, BY TOPICAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. DRUG DELIVERY MARKET SIZE, BY ADVANCED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. DRUG DELIVERY MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 14. DRUG DELIVERY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. DRUG DELIVERY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. DRUG DELIVERY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. DRUG DELIVERY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. DRUG DELIVERY MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 190. DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 191. DRUG DELIVERY MARKET LICENSE & PRICING
目次
Product Code: MRR-434CCDA0515A

The Global Drug Delivery Market is forecasted to grow significantly, with a projected USD 1,720.09 million in 2023 at a CAGR of 6.38% and expected to reach a staggering USD 2,658.96 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Drug Delivery Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Drug Delivery Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Oral Drug Delivery, market is studied across Injectable Drug Delivery, Nasal Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, and Topical Drug Delivery. The Injectable Drug Delivery is projected to witness significant market share during forecast period.

Based on Device Type, market is studied across Advanced and Conventional. The Conventional is projected to witness significant market share during forecast period.

Based on Distribution Channels, market is studied across Hospital Pharmacies and Retail Pharmacies. The Hospital Pharmacies is projected to witness significant market share during forecast period.

Based on Application, market is studied across Cancer, Cardiovascular Diseases, Diabetes, and Respiratory Diseases. The Diabetes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 35,944.71% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Drug Delivery Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Delivery Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Delivery Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Delivery Market?

4. What is the competitive strategic window for opportunities in the Global Drug Delivery Market?

5. What are the technology trends and regulatory frameworks in the Global Drug Delivery Market?

6. What is the market share of the leading vendors in the Global Drug Delivery Market?

7. What modes and strategic moves are considered suitable for entering the Global Drug Delivery Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Drug Delivery Market, by Oral Drug Delivery, 2022 vs 2030
  • 4.3. Drug Delivery Market, by Device Type, 2022 vs 2030
  • 4.4. Drug Delivery Market, by Distribution Channels, 2022 vs 2030
  • 4.5. Drug Delivery Market, by Application, 2022 vs 2030
  • 4.6. Drug Delivery Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of biological drugs worldwide
      • 5.1.1.2. Swelling demand for effective drug delivery mechanisms
      • 5.1.1.3. Significant increase in chronic diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Increasing drug recalls and drug failures
      • 5.1.2.2. Side effects and risk associated with the drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising demand for cost-effective healthcare treatment
      • 5.1.3.2. Growing focus towards home care and self-administration
    • 5.1.4. Challenges
      • 5.1.4.1. Pricing pressure and issues with patents expiry
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Drug Delivery Market, by Oral Drug Delivery

  • 6.1. Introduction
  • 6.2. Injectable Drug Delivery
  • 6.3. Nasal Drug Delivery
  • 6.4. Ocular Drug Delivery
  • 6.5. Pulmonary Drug Delivery
  • 6.6. Topical Drug Delivery

7. Drug Delivery Market, by Device Type

  • 7.1. Introduction
  • 7.2. Advanced
  • 7.3. Conventional

8. Drug Delivery Market, by Distribution Channels

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Retail Pharmacies

9. Drug Delivery Market, by Application

  • 9.1. Introduction
  • 9.2. Cancer
  • 9.3. Cardiovascular Diseases
  • 9.4. Diabetes
  • 9.5. Respiratory Diseases

10. Americas Drug Delivery Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Drug Delivery Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Drug Delivery Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing